Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-001302
Filing Date
2025-07-24
Accepted
2025-07-24 17:23:50
Documents
35
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acbm_10q.htm   iXBRL 10-Q 319943
2 CERTIFICATION acbm_ex311.htm EX-31.1 12981
3 CERTIFICATION acbm_ex321.htm EX-32.1 5464
  Complete submission text file 0001640334-25-001302.txt   1471987

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acbm-20250331.xsd EX-101.SCH 15114
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acbm-20250331_lab.xml EX-101.LAB 103998
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acbm-20250331_cal.xml EX-101.CAL 21037
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acbm-20250331_pre.xml EX-101.PRE 77197
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acbm-20250331_def.xml EX-101.DEF 22308
38 EXTRACTED XBRL INSTANCE DOCUMENT acbm_10q_htm.xml XML 112787
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55643 | Film No.: 251147946
SIC: 7900 Services-Amusement & Recreation Services
(CF Office: 07 Trade & Services)